Abstract:ObjectiveAxial spondyloarthritis (axSpA) is associated with decreased function and mobility of patients due to inflammation and radiographic damage. The Epionics SPINE device (ES), an electronic device that objectively measures spinal mobility, including range of motion (RoM) and speed (RoK) of movement, has been clinically validated in axSpA. We investigated the performance of the ES relative to radiographic damage in the axial skeleton of patients with axSpA.MethodsA total of 103 patients with axSpA (31 non-… Show more
“…10 11 Epionics SPINE (ES) is an electronic device capable of objectively assessing spinal mobility that was currently validated in axSpA. [10][11][12][13][14][15] Cross-sectional use of the common instruments like the BASMI is informative in patients with axSpA, and it has recently been shown also for patients with early axSpA. 16 However, the high variation of the measurements over time impairs their use at the individual patient level.…”
ObjectivePatients with axial spondyloarthritis (axSpA) suffer from clinical symptoms like morning stiffness and back pain. Mobility of patients with axSpA is often impaired. The aim of this study is to compare the performance of patients with axSpA regarding mobility measures including performance-based tests and objective electronic assessments with the Epionics SPINE device (ES) at different times of the day compared with healthy controls (HC).MethodsObservational trial, consecutive inpatients with axSpA (n=100) and 20 HCs were examined in the morning (V1: before 10:00 am) and in the afternoon (V2: after 02:00 pm) by the Bath Ankylosing Spondylitis Metrology Index (BASMI), the AS physical performance index (ASPI), the Short Physical Performance Battery (SPPB) and ES measurements, including range of motion (RoM) and range of kinematics (RoK).ResultsThe assessments of patients with axSpA performed in the morning clearly differed from those in the afternoon, especially regarding performance-based tests. Significant improvements were seen for BASMI (4.0±3.8 to 3.8±1.9; p<0.001), ASPI (36.2±18.3 to 28.8±11.9 s; p<0.001), SPPB (10.1±1.5 to 10.7±1.4 points; p<0.001) and for ES measures of speed (RoK; p<0.018) but not for RoM, except for lateral flexion (13.3±7.4 to 14.7±8.2°; p=0.002). This time of assessment-related variability was not observed in HC.ConclusionThe spinal mobility of patients with axSpA was worse in the morning but significantly improved in the afternoon. This was captured best by performance-based measures and was not seen in HC. The diurnal variation of mobility has implications for clinical studies, suggesting that the time of assessments needs to be standardised.
“…10 11 Epionics SPINE (ES) is an electronic device capable of objectively assessing spinal mobility that was currently validated in axSpA. [10][11][12][13][14][15] Cross-sectional use of the common instruments like the BASMI is informative in patients with axSpA, and it has recently been shown also for patients with early axSpA. 16 However, the high variation of the measurements over time impairs their use at the individual patient level.…”
ObjectivePatients with axial spondyloarthritis (axSpA) suffer from clinical symptoms like morning stiffness and back pain. Mobility of patients with axSpA is often impaired. The aim of this study is to compare the performance of patients with axSpA regarding mobility measures including performance-based tests and objective electronic assessments with the Epionics SPINE device (ES) at different times of the day compared with healthy controls (HC).MethodsObservational trial, consecutive inpatients with axSpA (n=100) and 20 HCs were examined in the morning (V1: before 10:00 am) and in the afternoon (V2: after 02:00 pm) by the Bath Ankylosing Spondylitis Metrology Index (BASMI), the AS physical performance index (ASPI), the Short Physical Performance Battery (SPPB) and ES measurements, including range of motion (RoM) and range of kinematics (RoK).ResultsThe assessments of patients with axSpA performed in the morning clearly differed from those in the afternoon, especially regarding performance-based tests. Significant improvements were seen for BASMI (4.0±3.8 to 3.8±1.9; p<0.001), ASPI (36.2±18.3 to 28.8±11.9 s; p<0.001), SPPB (10.1±1.5 to 10.7±1.4 points; p<0.001) and for ES measures of speed (RoK; p<0.018) but not for RoM, except for lateral flexion (13.3±7.4 to 14.7±8.2°; p=0.002). This time of assessment-related variability was not observed in HC.ConclusionThe spinal mobility of patients with axSpA was worse in the morning but significantly improved in the afternoon. This was captured best by performance-based measures and was not seen in HC. The diurnal variation of mobility has implications for clinical studies, suggesting that the time of assessments needs to be standardised.
“…8 In 2 recent studies, Kiefer et al leveraged an electronic tool, the Epionics SPINE device (ES), for more accurate spinal mobility measurements. 9,10 The ES comprises 2 strips of motion sensors linked to a computer. The sensor strips are attached to the back of the proband, parallel to the spine, 5 cm left and right of the midline, reaching from the level of the C7 spinous process to the posterior superior iliac spine.…”
Section: Editorial a Move Toward Precision: Innovations In Measuring ...mentioning
confidence: 99%
“…9 In this issue of The Journal of Rheumatology, the effect of syndesmophytes on spinal mobility was assessed using the ES. 10 The study involved 103 patients with axSpA, 72 with radiographic and 31 with nonradiographic disease; 43 patients had evidence for syndesmophytes on spinal radiographs. The patients with axSpA who had syndesmophytes were older than those without syndesmophytes, with a nonsignificant trend for longer disease duration.…”
Section: Editorial a Move Toward Precision: Innovations In Measuring ...mentioning
The efficacy of therapeutic interventions in axial spondyloarthritis (axSpA), including its more severe subset of ankylosing spondylitis (AS), is measured primarily using variables that reflect inflammatory activity. Most clinical trials have relied on the Assessment of Spondyloarthritis international Society 20 (ASAS20) or ASAS40 response as primary endpoints, whereas the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and particularly the Ankylosing Spondylitis Disease Activity Score, have proven useful for monitoring disease activity longitudinally.1,2
Background: Patients with axial spondyloarthritis (axSpA) are often compromised by impaired function and mobility. The standardized 2-week inpatient program ‘multimodal rheumatologic complex treatment’ (MRCT) was designed for patients with axSpA. The Epionics SPINE (ES) is an objective tool validated to assess mobility. Objective: To investigate the impact of MRCT on physical function and mobility including range of motion (RoM) and kinematics (RoK). Design: Single-center interventional, observational trial. Methods: Patients with axSpA presenting with high disease activity and impaired physical function were consecutively recruited to undergo MRCT. Assessments performed before (V1) and after (V2) the intervention included Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis functional index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), the ankylosing spondylitis physical performance index (ASPI), the Short Physical Performance Battery (SPPB), and ES measurements. Results: At baseline, the 80 patients included had: BASDAI 5.5 ± 1.5, BASFI 5.6 ± 2.0, BASMI 4.2 ± 1.8, SPPB 13.8 ± 1.8, and ASPI 37.3 ± 18.1 s. Clinically relevant improvements between V1 versus V2 were noted for BASFI, BASMI, and all other assessments ( p < 0.001), and also for ES measures of RoK (all p < 0.003) and RoM (all p < 0.04), while a positive trend was seen for flexion and extension (RoM). There was no significant effect of changes in medication (all p > 0.05). Conclusion: The 2-weeks MRCT was associated with definite improvements of function and mobility. Importantly, the effect of this extensive physical activity was confirmed by using the ES as an objective tool to assess spinal mobility. The ES demonstrated for the first time that the RoK of spinal mobility can significantly improve related to an exercise intervention. Trial registration: Ethical Committee: Ruhr-Universität (reference-number: 19-6735-BR).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.